| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d9d6b8eab2b38d95feb27531aef324 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de870844218c6776e8f82de5ac98dc6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761ac580276f677e91ada0d6f46f15ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d714e78db2edc0964a26ad532468dd1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a15949def011e9d2bc7a7df2eb229130 |
| publicationDate |
2008-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-200808354-A |
| titleOfInvention |
Furost-5-ene-3,22,26-triol glucoside compounds for cancer prevention and treatment |
| abstract |
The present invention provides a furost-5-ene-3,22,26-triol glucoside compounds for cancer prevention and treatment through the mechenism of promoting apoptosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-4177-C1 |
| priorityDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |